Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: An Emerging Clinical Challenge
Advances in Diabetes & Endocrinology · 2026 · 9 (1)
DOI: 10.13188/2475-5591.1000026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Diabetes & Endocrinology, 2026. Verfasst von Sibi Das.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetic ketoacidosis (DKA) is a life-threatening metabolic emergency characterized by insulin deficiency, ketonemia, and high-anion gap metabolic acidosis.Although traditionally associated with type 1 diabetes, DKA is increasingly recognized in Type 2 Diabetes Mellitus, particularly in the context of evolving therapies and metabolic stress.A notable shift in recent years is the emergence of euglycemic diabetic ketoacidosis (euDKA), defined as DKA with blood glucose levels
Zitieren
APA
Das, S. (2026). Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: An Emerging Clinical Challenge. Advances in Diabetes & Endocrinology, 9(1). https://doi.org/10.13188/2475-5591.1000026
Vancouver
Das S. Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: An Emerging Clinical Challenge. Advances in Diabetes & Endocrinology. 2026;9(1). doi:10.13188/2475-5591.1000026
BibTeX
@article{Das2026,
author = {Das, Sibi},
title = {Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes: An Emerging Clinical Challenge},
journal = {Advances in Diabetes & Endocrinology},
year = {2026},
volume = {9},
number = {1},
doi = {10.13188/2475-5591.1000026}
}
EUVIMED